Jessica Poole

Director, IBC Operations

Jessica Poole is a dedicated biosafety professional with over 15 years of experience in academia. Due to her career path, Jessica brings a broad range of expertise to Clinical Biosafety Services. She has experience in animal husbandry, development and maintenance of a select agent program, performing risk assessments of infectious agents and biological toxins, reviewing IBC protocols and IACUC applications, training laboratory personnel, ensuring compliance with applicable state and federal regulations, performing laboratory inspections and investigating accidents involving biological agents. She takes pride in being known as an out-of-the-box thinker, assisting clients in coming up with creative solutions, and creating enjoyable safety trainings (believe it or not).

Jessica received undergraduate degrees in Biology and Psychology from the University of North Carolina at Charlotte. In 2014, she received her graduate degree in Animal Science from NC State University.

Jessica began her career in animal husbandry at Duke University and eventually transitioned to biosafety at The University of North Carolina at Chapel Hill (Go Heels!). Most recently she served as the Biosafety Officer at Cleveland Clinic's Florida Research and Innovation Center.

Originally from North Carolina, she currently resides on Hutchinson Island in sunny Florida with her husband (Lance), twin boys (Graham and Grayson) and dog (Bailey). If Jessica is not working or being her boys' personal chauffeur, you will most likely find her on the beach reading a book or attending some sort of sporting event.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.